Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
117.50    2.00 (1.73%)
Bid:
116.50
Ask:
117.50
Spread: 1.00 (0.858%)
Market Cap: £259.73m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update re Financing Facility

28 Nov 2008 07:00

RNS Number : 1381J
Queen's Walk Investment Limited
28 November 2008
Β 

ο»Ώ

Update on QWIL's Financing Facility

As at 27 November 2008, the Company had drawn €40.5 million against its financing facility andΒ had undrawnΒ availabilityΒ of €94.5 million. Given current market yields,Β the CompanyΒ should beΒ able to achieve its return objectives on new investments without the need for additional leverage. In addition, in today's highly volatile markets, the Company could have been exposed to material change clauses that might have triggered the requirement for the repayment of the facility on unfavourable terms.

In light of these circumstances, the Company has successfully negotiated amended terms on a reduced facility, involving a flexible two year repayment schedule of the outstanding debt andΒ has reduced the riskΒ associated withΒ material change clausesΒ that could have forcedΒ a repayment of the debt on unfavourable terms.Β The Company's cash balance of €16.5Β millionΒ as at 27 November 2008Β and continued cash flows from its investment portfolio support the repayment schedule and the timely redemption of the loan facility. The Company believes thatΒ the renegotiated loan facility is moreΒ prudent than continued dependence onΒ anΒ unpredictableΒ lending market.

The Company hasΒ completed negotiations with its lenderΒ and the key elements of the amended facility are summarised below.

The Company has committed to repay the outstanding balance of the facility byΒ OctoberΒ 2011,Β pursuant to an agreedΒ loanΒ amortisation schedule and will not make any further draw downs. The CompanyΒ believesΒ it shouldΒ be able to satisfy the loan amortisation schedule with the €16.5 million ofΒ cashΒ currentlyΒ on the balance sheet and the expected cash flows from its investment portfolio. In addition, at the end of each quarter, the Company has pledged to keep theΒ outstanding balance of the financing facility below the product of the then applicable advance rateΒ ("Applicable Percentage")Β and the value of theΒ investment portfolio plus cashΒ (the "Borrowing Base"). At present, the Company's Borrowing Base is approximately €62.9Β millionΒ versus a loan balance of €40.5 million.Β 

At the end of each calendar quarter, the Company has agreed a target loan amount ("Target Loan Amount") with the lenders. The Company has also agreed to anΒ Applicable PercentageΒ for every quarter. The Target Loan Amount andΒ Applicable PercentageΒ Schedule are detailed below:

Date

Target Loan Amount

Applicable Percentage for Residuals

31 DecemberΒ 2008

35,000,000

30%

31 March 2009Β 

33,000,000

30%

30 June 2009Β 

31,000,000

30%

30 September 2009

28,500,000

30%

31 December 2009

27,000,000

27.5%

31 March 2010Β 

25,000,000

20%

30 June 2010

12,000,000

20%

30 September 2010

10,000,000

20%

31 December 2010

0

20%

31 March 2011

0

10%

TheΒ Applicable PercentageΒ for the Company's investment grade bond portfolio will be 50%, 40%, 30% and 15% for AA and above, A and above, BBB and above and BB and above; rated bonds respectively.

TheΒ Target Loan AmountΒ will reduce by €11 million in the event that the Magellan 1 transaction is re-financed by the originator, BCP Millennium, before June 2010. TheΒ Applicable PercentageΒ for residuals will reduce to 25% if the Magellan 1 transaction is re-financed by BCP Millennium before 31 December 2009.

The Company has committed to use a percentage of its Free Cash (cash proceeds in a quarter less dividends and operating expenses) to amortise the facility. Prior to the Magellan 1 transaction being refinanced, 75% of the Company's Free Cash will be used to repay the facility. After the Magellan 1 transaction is called, 66% of the Free Cash will be used to repay the debt. Once the outstanding balance of the facility is below €22 million, 50% of the Free Cash will be used to repay the facility. If the outstanding balance of the loan facility is less than the Target Loan Amount on the relevant date, the dividend will be capped at €2.25 million perΒ quarter (or approximately a 19% dividend yield on the share price as atΒ 26Β November 2008). If the Company is unable to satisfy theΒ loanΒ amortisation schedule, the dividend will be capped at 8%Β on the share price prevailing at the end of each quarter. A failure to meet the loan amortisationΒ schedule would not trigger an event of default.

In the event that the balance of the facility is greater than the Borrowing Base, the Company will have 20 business days to remedy the breach. Failure to remedy the breach would constitute an event of default.Β 

The Company has agreed to more asset specific tests in exchange for limiting the scope of the material change triggers and believes that the investment portfolio can support the amended facility.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCZGMZMFNMGRZZ
Date   Source Headline
4th Apr 20147:00 amRNSFact Sheet Announcement
28th Mar 20144:45 pmRNSTransaction in Own Shares
24th Mar 20147:00 amRNSFact Sheet Announcement
11th Mar 201410:56 amRNSTotal Voting Rights
10th Mar 20147:00 amRNSFact Sheet Announcement
4th Mar 20149:18 amRNSTR-1: Notification of Major Interest in Shares
24th Feb 20147:00 amRNSFact Sheet Announcement
12th Feb 20147:00 amRNSDividend Announcement
12th Feb 20147:00 amRNSDividend Announcement
12th Feb 20147:00 amRNSDividend Announcement
12th Feb 20147:00 amRNSInterim Management Statement
5th Feb 20147:00 amRNSFact Sheet Announcement
27th Jan 20143:17 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
20th Jan 20147:00 amRNSFact Sheet Announcement
8th Jan 20147:00 amRNSFact Sheet Announcement
19th Dec 20137:00 amRNSFact Sheet Announcement
16th Dec 20137:00 amRNSAppointment of New Director
10th Dec 20134:58 pmRNSTransaction in Own Shares
5th Dec 20137:00 amRNSFact Sheet Announcement
27th Nov 20137:00 amRNSDividend Declaration
27th Nov 20137:00 amRNSDividend Declaration
27th Nov 20137:00 amRNSCondensed Consolidated Interim Financial Report
27th Nov 20137:00 amRNSHalf Yearly Report
27th Nov 20137:00 amRNSFact Sheet Announcement
20th Nov 20139:10 amRNSTR-1: Notification of Major Interest in Shares
15th Nov 20132:58 pmRNSTR-1: Notification of Major Interest in shares
13th Nov 20135:27 pmRNSTR-1: Notification of Major Interest in Shares
11th Nov 201312:20 pmRNSResult of EGM
11th Nov 201310:09 amRNSNotice of Results
5th Nov 20137:00 amRNSConfirmation of price per new core share
5th Nov 20137:00 amRNSFact Sheet Announcement
28th Oct 20133:53 pmRNSTR-1: Notification of Major Interest in Shares
23rd Oct 20131:43 pmRNSTR-1: Notification of Major Interest in Shares
22nd Oct 201311:23 amRNSFact Sheet Announcement
17th Oct 20137:00 amRNSPosting of Circular and Notice of EGM
16th Oct 20134:48 pmRNSDividend Declaration
16th Oct 20134:47 pmRNSPublication of Prospectus
16th Oct 20134:45 pmRNSPlacing of New Core Shares
14th Oct 20134:19 pmRNSTR-1: Notification of Major Interest in Shares
11th Oct 20132:45 pmRNSTR-1: Notifcation of Major Interest in Shares
2nd Oct 201312:00 pmRNSFact Sheet Announcement
23rd Sep 20137:00 amRNSProposed Issue of Equity
18th Sep 201312:44 pmRNSFact Sheet Announcement
6th Sep 20137:00 amRNSFact Sheet Announcement
19th Aug 201312:33 pmRNSDirector/PDMR Shareholding
13th Aug 20137:00 amRNSDividend Declaration
13th Aug 20137:00 amRNSDividend Declaration
13th Aug 20137:00 amRNSInterim Management Statement
13th Aug 20137:00 amRNSERII Compulsory Redemption Announcement
12th Aug 201311:05 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.